NPPA Issues Demand Notice to Akums Drugs Subsidiary and Hetero Healthcare
Akums Drugs and Pharmaceuticals Ltd 路 Others (Uncategorized) 路 15 Oct 2026, 10:08 pm
NPPA Issues Demand Notice to Akums Drugs Subsidiary and Hetero Healthcare Akums Drugs and Pharmaceuticals' wholly-owned subsidiary, Pure and Cure Healthcare, alongside marketer Hetero Healthcare and Abaris Healthcare, received an NPPA demand notice dated 13th Oct'26 for Rs 52.75 cr. The demand relates to alleged DPCO 2013 pricing violations for formulation "Lanol 1000 mg injection" manufactured between Dec'17 and Aug'24, comprising Rs 18.95 cr overcharging, Rs 18.95 cr penalty, and Rs 14.85 cr interest. Akums clarified that primary response liability lies with marketer Hetero Healthcare under contractual indemnity clauses holding marketers solely liable for DPCO breaches.
Original exchange filing (PDF)
More announcements from Akums Drugs and Pharmaceuticals Ltd
- Intimation of Schedule of the Investors/Analysts Meet 路 10 Nov 2026
- Transcript of the Earning/Quarterly Conference Call on the unaudited financial results for the quarter and half year ended on September 30, 2026 路 05 Nov 2026
- Audio recording of Earning/ Quarterly Conference Call 路 03 Nov 2026
- Newspaper Publication 路 03 Nov 2026
- Final Report of CRISIL Ratings Limited, Monitoring Agency 路 03 Nov 2026
- Q2 FY 2026-27 - Investor Presentation 路 02 Nov 2026
- Press Release 路 02 Nov 2026
- Mr. Sanjay Kumar has been designated as Senior Management Personnel of the Company. 路 02 Nov 2026
